Skip to main content

Table 3 Summary of allergic adverse events per ITT participant during LTFU

From: Feasibility of sustained response through long-term dosing in food allergy immunotherapy

Reaction numbers per ITT participant

Total

Month 0–12

Month 13–24

Month 25–36

Month 37–48

Month 49–72

Number of participants followed during time period

46

46

46

46

41

23

Total reactions per ITT participant median (range)

25 (0–35)

15 (0–21)

5 (0–7)

2 (0–3)

0 (0–1)

0

Gastrointestinal

4 (0–4)

2 (0–3)

0 (0–1)

0 (0–1)

0

0

 Mild

2 (0–3)

1 (0–2)

0 (0–1)

0 (0–1)

0

0

 Moderate

0 (0–2)

0 (0–1)

0

0

0

0

 Severe

0

0

0

0

0

0

Respiratory/thoracic/mediastinal

2 (0–6)

1 (0–4)

0 (0–1)

0 (0-1)

0

0

 Mild

1 (0–5)

1 (0–4)

0

0

0

0

 Moderate

0 (0–1)

0

0 (0–1)

0 (0–1)

0

0

 Severe

0

0

0

0

0

0

Skin/subcutaneous

8 (0–9)

5 (0–47)

2 (0–4)

1 (0–2)

0

0

 Mild

7 (0–9)

4 (0–27)

1 (0–2)

1 (0–1)

0

0

 Moderate

1 (0–3)

2 (0–20)

1 (0–1)

0 (0–1)

0

0

 Severe

0 (0–1)

0 (0–2)

0 (0–1)

0

0

0

Eye

1 (0–2)

0 (0–5)

0 (0–1)

0 (0–1)

0

0

 Mild

1 (0-2)

0 (0–5)

0 (0–1)

0 (0–1)

0

0

 Moderate

0

0

0

0

0

0

 Severe

0

0

0

0

0

0

Cardiovascular

0

0

0

0

0

0

Nasal congestion

6 (0–10)

3 (0–5)

2 (0–4)

1 (0–1)

0

0

 Mild

6 (0–10)

3 (0–5)

2 (0–4)

1 (0–1)

0

0

 Moderate

0 (0–2)

0 (0–1)

0 (0–1)

0

0

0

 Severe

0 (0–1)

0 (0–1)

0

0

0

0

Other (i.e. anxiety)

6 (0–21)

3 (0–44)

1 (0–2)

0 (0–1)

0 (0–1)

0

 Mild

6 (0-21)

3 (0–44)

1 (0–2)

0 (0–1)

0 (0–1)

0

 Moderate

0

0

0

0

0

0

 Severe

0

0

0

0

0

0